Mark Oneill

Technical Development at Opthea - South Yarra, VIC, AU

Mark Oneill's Contact Details
HQ
61-3-9826-0399
Location
Denver,Colorado,United States
Company
Opthea
Mark Oneill's Company Details
Opthea logo, Opthea contact details

Opthea

South Yarra, VIC, AU • 20 - 49 Employees
BioTech/Drugs

Opthea is a clinical stage biopharmaceutical company committed to developing innovative therapies to help improve visual function in patients suffering with retinal diseases. Our first in class novel therapeutic called OPT-302, is a VEGF-C/D ‘trap', to be used in combination with existing standard of care anti-VEGF-A therapies to improve vision in patients, many of whom respond sub-optimally or become refractory to existing treatments. Millions of people around the world suffer from impaired vision as a result of diabetes and old age. Our mission is to improve vision leading to a better quality of life. Enquiries can be directed to: info@opthea.com

Ophthalmological drug development
Details about Opthea
Frequently Asked Questions about Mark Oneill
Mark Oneill currently works for Opthea.
Mark Oneill's role at Opthea is Technical Development.
Mark Oneill's email address is ***@opthea.com. To view Mark Oneill's full email address, please signup to ConnectPlex.
Mark Oneill works in the Research industry.
Mark Oneill's colleagues at Opthea are Judy Robertson, Mike Gerometta, Megan Baldwin, Annette Leahy, Clare Price, Richard Chadwick and others.
Mark Oneill's phone number is 61-3-9826-0399
See more information about Mark Oneill